acquisitions Biology Biopharma Biopharmaceuticals biotech Biotech Billionaire Biotech Hub Breaking In Biotech Buyout Inclisiran low-density lipoprotein (LDL) Medicine Co. Novartis ow-density lipoprotein Pcsk9 PCSK9 Inhibitor Pharma Science siRNA The Medicines Company
Novartis Acquires The Medicines Company for $9.7 Billion
A Global Switzerland Pharmaceutical, Novartis, has agreed to acquire Medicines Company (NASDAQ: MDCO) for a staggering $9.7 Billion. The MedicinesContinue Reading
